首页 >
法规速递
-
Document: Highlights - 13th Industry Standing Group (ISG) meeting-2025/8/4
2025-08-05查看详情 > -
Document: Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (22 August 2025 - 18 September 2025)-2025/9/23
2025-09-24查看详情 > -
Document: Business process description for pharmacovigilance-2025/10/29
2025-10-30查看详情 > -
Document: Vaccine platform technology master file (vPTMF) submission letter template-2025/11/28
2025-12-01查看详情 > -
国家药监局综合司关于公开征求《麻醉药品和精神药品生产经营管理办法（征求意见稿）》意见-2025/12/30
2025-12-31查看详情 > -
Page: Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices-2026/2/6
2026-02-09查看详情 > -
国家药监局关于修订四季感冒片和四季感冒胶囊药品说明书的公告（2026年第28号）-2026/3/17
2026-03-18查看详情 > -
国家药监局关于发布仿制药参比制剂目录（第一百零四批）的通告（2026年第12号）-2026/4/20
2026-04-21查看详情 > -
Scientific guideline: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guideline Q9 (R1) on quality risk management - Step 5 - Revision 1-2023/02/06
2023-02-06查看详情 > -
国家药监局关于修订洛芬待因制剂说明书的公告（2023年第111号）-2023/8/29
2023-09-01查看详情 >
